Clinical Trials
9 trialsNCT06274541 2026-04-13
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
Cancer Trials Ireland
Completed
NCT01445275 2024-08-21
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199
GOG Foundation
Withdrawn
NCT01366183 2021-09-30
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
GOG Foundation
Unknown
NCT01139957 2020-09-02
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
GOG Foundation
Completed
NCT01372787 2019-03-12
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
GOG Foundation
Unknown
NCT00899093 2018-05-22
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
GOG Foundation
Terminated
NCT01295489 2018-05-22
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
GOG Foundation
Completed
NCT01080521 2018-04-12
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
GOG Foundation
Completed
NCT00897442 2016-10-28
Collecting Tumor Samples From Patients With Gynecological Tumors
GOG Foundation
Completed